scGRNom: a computational pipeline of integrative multi-omics analyses for predicting cell-type disease genes and regulatory networks

Genome Med. 2021 May 27;13(1):95. doi: 10.1186/s13073-021-00908-9.

Abstract

Understanding cell-type-specific gene regulatory mechanisms from genetic variants to diseases remains challenging. To address this, we developed a computational pipeline, scGRNom (single-cell Gene Regulatory Network prediction from multi-omics), to predict cell-type disease genes and regulatory networks including transcription factors and regulatory elements. With applications to schizophrenia and Alzheimer's disease, we predicted disease genes and regulatory networks for excitatory and inhibitory neurons, microglia, and oligodendrocytes. Further enrichment analyses revealed cross-disease and disease-specific functions and pathways at the cell-type level. Our machine learning analysis also found that cell-type disease genes improved clinical phenotype predictions. scGRNom is a general-purpose tool available at https://github.com/daifengwanglab/scGRNom .

Keywords: Alzheimer’s disease; Cell-type disease risk genes; Cell-type gene regulatory network; Cross-disease functional genomics; Schizophrenia; Single-cell genomics; Single-cell multi-omics integration.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Chromatin Immunoprecipitation Sequencing
  • Computational Biology / methods*
  • DNA-Binding Proteins
  • Gene Expression Regulation
  • Gene Regulatory Networks*
  • Genetic Association Studies / methods
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study* / methods
  • Genomics* / methods
  • Humans
  • Models, Biological
  • Organ Specificity / genetics
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Regulatory Sequences, Nucleic Acid
  • Software*

Substances

  • DNA-Binding Proteins